Phenotypic variations in gentamicin-resistant isolates of Staphylococcus aureus

Area of Science:

• Microbiology
• Molecular Biology
• Antimicrobial Resistance

Background:

• Aminoglycosides are crucial antibiotics for treating Gram-positive bacterial infections.
• Staphylococcus aureus is a significant human pathogen, frequently developing antibiotic resistance.
• High-level aminoglycoside resistance (HLAR) in S. aureus poses a therapeutic challenge.

Purpose of the Study:

• To characterize eight clinical isolates of Staphylococcus aureus with high-level resistance to seven aminoglycosides.
• To investigate the underlying mechanisms of aminoglycoside resistance in these isolates.
• To explore phenotypic variations associated with aminoglycoside resistance in S. aureus.

Main Methods:

• Isolation and characterization of eight clinical Staphylococcus aureus strains.
• Phenotypic analysis including colonial morphology and biochemical activity assays.
• Determination of aminoglycoside resistance profiles through susceptibility testing.

Main Results:

• All eight clinical isolates demonstrated high-level resistance to seven tested aminoglycosides.
• Resistance was not attributed to classical aminoglycoside-modifying enzyme inactivation.
• Resistant strains exhibited distinct variations in colonial morphology and biochemical properties.

Conclusions:

• The study identified Staphylococcus aureus isolates with significant aminoglycoside resistance.
• Mechanisms of resistance may involve pathways other than enzyme inactivation.
• Phenotypic heterogeneity exists among resistant S. aureus strains, potentially impacting diagnostic and therapeutic strategies.